2023-11-09T09:37:30-05:00 2022-12-31 042666565 John M Monticone CPA 5 High Street Suite 207 Medford MA 02155 990 2022-01-01 043333682 BEDFORD RESEARCH FOUNDATION BEDF 124 SOUTH ROAD Bedford MA 017302344 Ann Kiessling PhD President 6172817902 2023-11-15 true Ann Kiessling PhD John M Monticone CPA P01257043 7813950024 2023-11-09 X 0 00 AAL2 IAL1 2022 2023-04-26 12:10:37Z Ann Kiessling PhD 968642 false X WWW.BEDFORDRESEARCH.ORG X 1996 MA Stem cell research, prostate disease research and HIV Research. 16 14 13 14 0 0 1451028 65564 1755684 582399 53996 120679 0 3260708 768642 0 0 529026 596097 0 35825 391623 361069 920649 957166 2340059 -188524 4535026 3832619 65638 29892 4469388 3802727 Stem cell research, prostate disease research and HIV Research. false false 824516 575063 Special program of Assisted Reproduction takes advantage of Assited Reproduction Technology procedures to assist couples achieve a pregnancy who would otherwise risk transmitting the fathers infection to the mother and the child through intercourse. During this process, researches gathered information to prevent the transmission of sexually transmitted deseases. HIV Research. 31324 7336 Emergency COVID-19 Testing: In response to the emergency call from the Secretary of Health and Human Services from Massachusetts, the Organization, as a non-profit independent research organization, determined that at this time of crisis, this time of action was within its mission scope and undertook the COVID testing for the next several months, meeting the needs of its immediate community, as well as many managed health care communities through out the Commonwealth of Massachusetts. The Governors Command Center praised the Organization for its availability to run over 240 test per day and its ability to get results within 24 hours.The testing provided crucial results to Hospitals, Long-term care facilities, and several other miscellaneous organizations when testing was in short supply and results took longer than one week to be returned. (Continued in Schedule O)This program concluded in 2022. 855840 true true false false false false false false false false true false false false false true true false false false false false false false false false false false false false false false false false false false false true false false false false false false false false false true 2 0 true 13 true false false false false false false false false false false false false false false false false false X 16 14 false false false false false false false true false false false true true true true true true true false false MA X X Ann Kiessling PhD 6172817902 124 SOUTH ROAD Bedford MA 017302344 Ryan Kiessling Ex-officio 40.00 0.00 X 127083 0 0 Ann Kiessling PhD President 40.00 0.00 X X 92501 0 0 Lawrence R Jones MS Director 0.30 0.00 X 0 0 0 Yael Schwartz PhD Director 0.30 0.00 X 0 0 0 Susan L Moss JD PhD Director 0.30 0.00 X 0 0 0 Jose Cibelli DVM PhD Director 0.30 0.00 X 0 0 0 Alan Mayer Director 0.30 0.00 X 0 0 0 Sean Kealy Esq Director 0.30 0.00 X 0 0 0 Scott C Anderson Director 0.30 0.00 X 0 0 0 Anil Purohit PhD Director 0.30 0.00 X 0 0 0 John D Lee MEd Secretary 0.30 0.00 X 0 0 0 Ellen Sheehy MBA Director 0.30 0.00 X 0 0 0 Robert A Kaufmann MD Director 0.30 0.00 X 0 0 0 Margaret Wray BSN Director 0.30 0.00 X 0 0 0 Alan Geismer Esq Chairman of the Board 0.30 0.00 X X 0 0 0 Larry LaFranchi MBA Treasurer 1.00 0.00 X X 0 0 0 219584 0 0 1 false false false 65564 65564 Assisted reproduction 621500 575063 575063 Covid 19 Testing 621500 7336 7336 582399 120679 120679 200000 200000 768642 582399 0 120679 219586 172356 27167 20063 318052 300765 10468 6819 8562 7535 599 428 5133 4517 359 257 44764 39393 3134 2237 5168 5168 5500 5500 19200 14000 5200 2811 2548 263 2904 2556 203 145 3012 2650 211 151 85972 75655 6018 4299 6539 5754 458 327 5 5 31711 31711 7547 6642 528 377 SPAR Merchant ID Charges 19068 19068 Postages 5771 5078 404 289 Lab supplies 152831 152831 Repairs and maintenance 8652 7613 606 433 4378 4378 957166 855840 65501 35825 529254 142532 321832 287726 3168 22000 4000 4000 375667 253575 98443 122092 3566329 3242269 12000 12000 4535026 3832619 28785 13383 36853 16509 65638 29892 X 4469388 3780727 22000 4469388 3802727 4535026 3832619 -188524 -478137 0 X X false true X true false X 53178 75931 111018 227445 65564 533136 961093 783152 1779566 1755684 582399 5861894 1014271 859083 1890584 1983129 647963 6395030 43720 30000 24981 34195 34649 167545 43720 30000 24981 34195 34649 167545 6227485 21374 27849 11472 61630 120679 243004 21374 27849 11472 61630 120679 243004 1035645 886932 1902056 2044759 768642 6638034 0.93820 0.95390 0.04000 0.02000 X RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED RESTRICTED 29529 29529 346138 224046 122092 122092 Security Deposit 12000 12000 X 290504 -478137 -1 -478138 768642 768642 957165 -1 -1 957166 957166 Other revenues not included on Form 990 (Part XI, line 2d) Fractional adjustment Other expenses not included on Form 990 (Part XII, line 2d) Fractional adjustment Footnote for uncertain tax position under FIN 48 (Part X) The Organization has evaluated the tax positions taken on returns for open years and those expected to be taken on returns for the year ended December 31, 2022. It is Managements belief that such tax positions are more likely than not to be sustained upon examination by tax authorities. Accordingly, no liability for uncertain tax positions is reflected in these financial statements. Returns for tax years beginning with those filed for the year ended June 30, 2019 are open to examination. Dr Ann Kiessling PhD PresidentExecDirector 85972 See supplemental information false Ryan Kiessling President & Exec Directors son 127083 Compensation as Operations Director false DrAnn Kiessling PhD PresidentExecutive Director 92501 Compensation as Executive Director false Supplemental Information for Schedule L Compensation paid to Related Party:During the year, the Organization paid compensation of $92,501 to the President of the Organization, who ran the day-to-day operations of the Organization and $127,083 to the Presidents son, who is the Operations Director of the Organization. All related party transactions were approved by a vote of the disinterested Board members. Part IV - Business Transactions Involving Interested Persons:During the year 2016, the Organization has signed a lease for Office space with a for profit entity, which is owned by the President and board member of the Organization. The lease calls for current monthly base rent, including utilities, of $7,262. For the year 2022, the Organization paid $85,972 in rent to this related party. This transaction was approved by a vote of the disinterested Board Members. Committee meeting documentation Part VI line 8b No committee has the authority to act on behalf of the governing body. Form 990 governing body review Part VI line 11 Two weeks before filing the 990 form, a copy is given to each board of directors for review and discussion. Conflict of interest policy compliance Part VI line 12c The organization requires each new key employee, officer or director to review a copy of the Policy on Conflict of Interest and Disclosure of Certain Interests and to acknowledge in writing that he or she has done so. Additionally, each key employee, officer or director, annually complete a disclosure form identifying any relationships, positions or circumstances in which the employee is involved that he or she believes could contribute to a conflict of interest arising. CEO executive director top management comp Part VI line 15a The board of directors establishes the compensation for the Executive Director that are within the range or organizations similar in size and scope of Bedford Research Foundation. Governing documents etc available to public Part VI line 19 Copy of the financial statements and current year changes in the governing documents, conflict of interest policy are attached to the PC Form which is filed in the Secretary of State and available for public inspection. Also, copy of these documents are available at the organizations office at 124 South Road, Bedford, MA 01730, for public inspection upon request. Audited by an independent accountant Part XII line 2b The Organizations President and Treasurer have the responsibility to oversight the Review and the selection of the independent accountant. Explanation of other changes in net assets or fund balances Part XI line 9 Market Value depreciation of investments. General explanation attachment Form 990, Page 2, Part III, Line 4a- Program Service AccomplishmentsLarge national laboratories could not process these tests until October or even November at a reasonable turnaround time for treatment; the Organization clinical laboratory was deemed imperative during this time. The test performed in the Foundation laboratory is a molecular PCR test, which was not available at commercial re-sellers until several months into the pandemic. Once testing was more readily available, organizations began to use other commercial labs offering this testing. There was no attempt to recapture or develop a business product line; the Foundation responded to the demand as defined by its mission until after other testing courses became avaiable in early 2021, when the Foundations scientist resumed their research. The staff worked 10-12-hour days, seven days a week, and were often at the lab until late in the evening due to their dedication to serving the community.